Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  IGF ligand neutralizing antibody BI 836845
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
BI 836845 Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 1280.16, NCI-2015-01371, NCT02191891
BI 836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 1280.8, NCI-2015-01372, 2013-004011-41, NCT02204072
Start Over